FDA approves pill that cuts COVID risk nearly 70%

AI justification

FDA approval of highly effective COVID-19 prophylaxis advances global health and reduces suffering. | The FDA's approval of ensitrelvir represents a significant public health advancement by providing an effective tool to reduce COVID-19 transmission, directly supporting SDG 3 (Good Health and Well-being). The drug's high efficacy in post-exposure prophylaxis addresses a critical gap in pandemic preparedness and aligns with universal human rights to health and safety.